The brain is a fragile organ that is constantly being destroyed.
A patient’s brain can swell, tear and break down in different ways.
But scientists have been working for decades to create a cure.
Here’s what they’ve discovered about how it works.
Read moreA new study from the National Institutes of Health (NIH) and the Mayo Clinic (MGH) shows that a new drug, which is designed to slow the destruction of brain cells, can stop brain cancer cells from spreading.
It’s a promising new drug.
The researchers are now testing it on mice, rats and humans.
The NIH and MGH researchers were looking for drugs that would inhibit the development of new cancer cells in the brains of mice, so they could test new drugs in humans.
Their next step was to see if the drugs could stop brain cancers from spreading to people.
Mice were tested to see how well the drugs worked, and how effective they were at blocking the spread of the brain tumors to other parts of the body.
The scientists then turned to humans to see whether the drugs would be effective in blocking brain cancer in people.
They were looking to see what would happen if patients took a different drug called pembrolizumab, which can be given to treat melanoma.
Pembrolazepine, or pembro, is a compound similar to the active ingredient in Advil that inhibits tumor growth.
In humans, it’s known as escitalopram.
The researchers saw that the pembromin inhibitors slowed the spread in mice of melanoma cells to other organs, such as the brain, but not to other tissues.
When the drug was given to humans, however, the tumors disappeared.
“We are hopeful that our findings will lead to a better understanding of how this drug works in humans,” said Dr. Meeghan Johnson, a professor of neurosurgery and neurosurgeons at the Mayo School of Medicine in Rochester, Minnesota.
The results are published in the journal Science Translational Medicine.
The study involved 14 patients with melanoma and two healthy controls.
All the patients were on pembroxime or escitalipine or pemeximab.
In one of the patients, pembroglutamate, the drug that is used to treat severe and incurable forms of the disease, had no effect on tumor growth or spread.
In contrast, in the other patient, pemepro, which blocks tumor growth and spread, was able to stop brain tumor growth in the mice that were given the drug.
“This is a really good result.
This is an important step forward in understanding the mechanisms involved,” Johnson said.
“We’re hopeful that this will be helpful in finding new drugs that can be tested in humans.”
The study is the first to show that pembropionate, which was originally approved to treat patients with severe and fatal forms of brain cancer, could be used to stop the spread to other bodies.
The drugs also showed that they could help the brains heal themselves, and could prevent other tumors from growing and spreading.
“It shows that we have a compound that blocks tumor formation and is very effective at stopping tumor growth,” said study researcher Jennifer Peeples, of the Mayo Neuroscience Center at MGH.
“It’s very exciting.”
While these results are encouraging, they do not show that the drugs will be safe in people with brain cancer.
The study team is now working to figure out what happens to patients after taking them for a few months.
It’s possible that the new drugs could lead to some side effects.
“If there are side effects, that’s really not that bad, but it could be worse,” Johnson noted.
“So we’re not really confident that it’s safe.”
If the drugs can work in humans, they could be helpful for other forms of cancer.
“There’s lots of other research on these drugs, and it’s very promising,” Johnson added.